Scheer, I.; Becker, I.; Schmitter, C.; Semrau, S.; Fietkau, R.; Gaipl, U.S.; Frey, B.; Donaubauer, A.-J.
Prospective Evaluation of CD45RA+/CCR7- Effector Memory T (TEMRA) Cell Subsets in Patients with Primary and Secondary Brain Tumors during Radiotherapy of the Brain within the Scope of the Prospective Glio-CMV-01 Clinical Trial. Cells 2023, 12, 516.
https://doi.org/10.3390/cells12040516
AMA Style
Scheer I, Becker I, Schmitter C, Semrau S, Fietkau R, Gaipl US, Frey B, Donaubauer A-J.
Prospective Evaluation of CD45RA+/CCR7- Effector Memory T (TEMRA) Cell Subsets in Patients with Primary and Secondary Brain Tumors during Radiotherapy of the Brain within the Scope of the Prospective Glio-CMV-01 Clinical Trial. Cells. 2023; 12(4):516.
https://doi.org/10.3390/cells12040516
Chicago/Turabian Style
Scheer, Ilka, Ina Becker, Charlotte Schmitter, Sabine Semrau, Rainer Fietkau, Udo S. Gaipl, Benjamin Frey, and Anna-Jasmina Donaubauer.
2023. "Prospective Evaluation of CD45RA+/CCR7- Effector Memory T (TEMRA) Cell Subsets in Patients with Primary and Secondary Brain Tumors during Radiotherapy of the Brain within the Scope of the Prospective Glio-CMV-01 Clinical Trial" Cells 12, no. 4: 516.
https://doi.org/10.3390/cells12040516
APA Style
Scheer, I., Becker, I., Schmitter, C., Semrau, S., Fietkau, R., Gaipl, U. S., Frey, B., & Donaubauer, A.-J.
(2023). Prospective Evaluation of CD45RA+/CCR7- Effector Memory T (TEMRA) Cell Subsets in Patients with Primary and Secondary Brain Tumors during Radiotherapy of the Brain within the Scope of the Prospective Glio-CMV-01 Clinical Trial. Cells, 12(4), 516.
https://doi.org/10.3390/cells12040516
